Browse by author
Lookup NU author(s): Professor Robert Wilkinson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objective In this randomized, double-blind, crossover study, the antihypertensive efficacy of amlodipine and nifedipine gastrointestinal therapeutic system (GITS) was compared following missed doses. Design and methods In a randomized crossover design, 42 patients were randomized to receive amlodipine (5-10 mg) or the GITS formulation of nifedipine (nifedipine GITS) (30-60 mg) once daily for 12 weeks, then vice versa. During weeks 8, 10 and 12 of each treatment period, compliance failures were simulated by patients missing 0,1 or 2 doses of their medication, and ambulatory systolic (SBP) and diastolic (DBP) blood pressure measurements were obtained. Results Following steady-state treatment (i.e. 'perfect compliance'), there was no difference between amlodipine and nifedipine GITS in SBP (140.1 versus 134.2 mmHg) or DBP (84.0 versus 85.8 mmHg) at 0-24 h post-dose. When compliance was not perfect, i.e. when one or two doses were missed, DBP was maintained at a significantly lower level with amlodipine compared with nifedipine GITS at 24-48 h post-dose (83.1 versus 86.4 mmHg, P = 0.005) and at 48-72 h post-dose (84.2 versus 89.7 mmHg, P < 0.001). Plasma concentrations of amlodipine were better maintained than those of nifedipine GITS. At 72 h post-dose, the plasma concentration of amlodipine was 61% (17.0 +/- 11.2 ng/ml) compared with < 25% (28.3 +/- 49.9 ng/ml) for nifedipine GITS. Conclusion During short periods of non-compliance, antihypertensive efficacy remains more predictable with amlodipine than with nifedipine GITS. (C) 2002 Lippincott Williams Wilkins.
Author(s): Elliott HL, Elawad M, Wilkinson R, Singh SP
Publication type: Article
Publication status: Published
Journal: Journal of Hypertension
ISSN (print): 0950-9240
ISSN (electronic): 1476-5527
Publisher: Nature Publishing Group
Altmetrics provided by Altmetric